Clovis Oncology, Inc.

GAMCO INVESTORS, INC. ET AL

Report date

9/30/2022

Quarter

2022 Q3

Filed

11/14/2022

Shares

145,400

Value ($000)

173

Weight

0.0%

2019 Q4 - 2022 Q3 (12 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2022 Q3	11/14/2022	173	0.0%	145,400	9/30/2022
2022 Q2	8/12/2022	285	0.0%	158,350	6/30/2022
2022 Q1	5/18/2022	350	0.0%	173,050	3/31/2022
2021 Q4	2/11/2022	455	0.0%	168,050	12/31/2021
2021 Q3	11/12/2021	875	0.0%	196,300	9/30/2021
2021 Q2	8/13/2021	1,191	0.0%	205,300	6/30/2021
2021 Q1	5/14/2021	1,386	0.0%	197,450	3/31/2021
2020 Q4	2/5/2021	1,538	0.0%	320,450	12/31/2020
2020 Q3	11/6/2020	1,821	0.0%	312,300	9/30/2020
2020 Q2	8/13/2020	2,159	0.0%	319,900	6/30/2020
2020 Q1	5/14/2020	1,982	0.0%	311,600	3/31/2020
2019 Q4	2/14/2020	3,207	0.0%	307,630	12/31/2019